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Abstract
Background: Aging influences immune response and susceptibility to EAE in a strain specific manner. The study
was designed to examine influence of aging on EAE induction in Albino Oxford (AO) rats.
Results: Differently from 3-month-old (young) rats, which were resistant to EAE induction, the majority of aged
(24-26-month-old) rats developed mild chronic form of EAE. On 16th day post-immunization, when in aged rats the
neurological deficit reached plateau, more mononuclear cells, including CD4+ T lymphocytes was retrieved from
spinal cord of aged than young rats. The frequencies of IL-17+ and GM-CSF+ cells within spinal cord infiltrating
CD4+ lymphocytes were greater in aged rats. To their increased frequency contributed the expansion of GM-CSF +
IL-17 + IFN-γ+ cells, which are highly pathogenic in mice. The expression of the cytokines (IL-1β and IL-23/p19)
driving GM-CSF + IL-17 + IFN-γ + cell differentiation in mice was also augmented in aged rat spinal cord mononuclear
cells. Additionally, in aged rat spinal cord the expansion of GM-CSF + IL-17-IFN-γ- CD4+ T lymphocytes was found.
Consistently, the expression of mRNAs for IL-3, the cytokine exhibiting the same expression pattern as GM-CSF, and
IL-7, the cytokine driving differentiation of GM-CSF + IL-17-IFN-γ- CD4 + lymphocytes in mice, was upregulated in aged
rat spinal cord mononuclear cells, and the tissue, respectively. This was in accordance with the enhanced generation
of the brain antigen-specific GM-CSF+ CD4+ lymphocytes in aged rat draining lymph nodes, as suggested by (i) the
higher frequency of GM-CSF+ cells (reflecting the expansion of IL-17-IFN-γ- cells) within their CD4+ lymphocytes and
(ii) the upregulated GM-CSF and IL-3 mRNA expression in fresh CD4+ lymphocytes and MBP-stimulated draining lymph
node cells and IL-7 mRNA in lymph node tissue from aged rats. In agreement with the upregulated GM-CSF expression
in aged rats, strikingly more CD11b + CD45int (activated microglia) and CD45hi (mainly proinflammatory dendritic cells
and macrophages) cells was retrieved from aged than young rat spinal cord. Besides, expression of mRNA for SOCS1,
a negative regulator of proinflammatory cytokine expression in innate immunity cells, was downregulated in aged rat
spinal cord mononuclear cells.
Conclusions: The study revealed that aging may overcome genetic resistance to EAE, and indicated the cellular and
molecular mechanisms contributing to this phenomenon in AO rats.
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Background
Multiple sclerosis (MS) is a complex inflammatory auto-
immune disease of the central nervous system (CNS)
with heterogeneous clinical, pathological and immuno-
logical phenotype that might better be described as a
syndrome rather than a single disease entity. The eti-
ology of MS is not well understood, but it is believed
that myelin-specific CD4+ T cells play a central role in
initiating and orchestrating CNS inflammation [1]. Their
role has been studied extensively, principally by using
experimental autoimmune encephalomyelitis (EAE), an
animal model of MS. EAE can be actively induced in
susceptible strains of mice and rats by immunization
with either whole spinal cord homogenate or encephali-
togenic proteins or peptides in adjuvants. Both Th1 and
Th17 cells have been implicated in MS/EAE develop-
ment [1, 2]. Thus, the role of CD4+ cells in MS/EAE
pathogenesis has been called the Th1/Th17 paradigm
[3]. However, there is a body of evidence indicating that
Th1 and Th17 cytokines are dispensable for the develop-
ment of EAE [4–7]. Additionally, granulocyte macro-
phage colony-stimulating factor (GM-CSF) is suggested
to be the only known cytokine produced by T cells that
is required for susceptibility to EAE [8]. Furthermore,
the pathogenicity of autoreactive Th17 cells has been
associated with their production of GM-CSF [8, 9]. Al-
though Th1 cells are also shown to produce GM-CSF,
they most likely do not represent an important source of
GM-CSF in EAE [8]. Recently, IL-7-STAT5 signalling
axis-induced CD4+ T cells are suggested to be the major
source of GM-CSF in T cell-mediated neuroinflamma-
tion [10]. Besides, they are thought to represent a new
Th subset with a distinct differentiation program and
cytokine production profile [10]. This subset has been
designated as Th-GM subset [10]. GM-CSF accelerates
the release of bone marrow precursors that ultimately
differentiate into the CNS-infiltrating dendritic cells and
macrophages [11], and provides activation/expansion of
cells belonging to the myeloid lineage, which in turn
promote (i) Th-GM cell activation/differentiation and
(ii) tissue destruction through release of various bio-
active molecules [8, 9, 12, 13].
The MS typically begins between the ages of 20 and
40 years, whereas initial symptoms rarely occur before
age of 10 years or after age of 60 years [14]. Data on the
influence of aging on the incidence and clinical course
of actively induced EAE are limited and inconsistent
[15–21]. This inconsistency most likely could be as-
cribed to species and strain differences, differences in
animal chronological (and possibly biological) age and
immunization protocols. The discrepancy between data
obtained in humans and in animal models, apart from
differences in etiopathogenesis [22–24], could also re-
flect the fact that influence of aging on autoimmune
neuroinflammation has been studied in inbred rodent
strains, while, though there are human populations of
relative genetic homogeneity (e.g. Amish), in most hu-
man populations there is significant genetic diversity
[25]. Despite all the aforementioned, the investigations
of influence of aging on EAE development in distinct
rodent strains are important as they not only offer a
window into the putative mechanisms underlying MS
development, but also broaden our understanding of
age-related immune changes.
Albino Oxford (AO) rats are relatively resistant to
EAE induction [26]. More specifically, their resistance to
EAE induction is not absolute, but quantitative, as min-
imal single cell infiltrate is regularly seen (independently
on immunization protocol) in spinal cord of AO rats al-
though they do not develop clinical signs of EAE [27].
Furthermore, resistance of AO rats to EAE is not due to
their inability to recognize determinants of myelin basic
protein (MBP) [26]. Their resistance is suggested to be
related to the differences in immunoregulatory circuits
affecting either antigen presenting cells or lymphocytes
with regulatory properties [26]. Our recent studies
showed that aging markedly affects phenotypic and
functional characteristics of splenic myeloid dendritic
cells from AO rats, and that this effect is strain-specific
[28, 29]. In the rat, dendritic cell subset composition
correlates with their susceptibility to autoimmune dis-
ease induction and Th polarization [30, 31]. The greater
proportion of CD4-CD11b + OX62+ cells (producing
large amount of proinflammatory cytokines) within den-
dritic cell population has been associated with a greater
susceptibility to Th1/Th17-mediated diseases [30, 31]. In
AO rats, age-related increase in the relative proportion
of CD4-CD11b + OX62+ cells within splenic myeloid
dendritic cells was found [28]. Consistently, in vitro
LPS-activated splenic myeloid dendritic cells from aged
AO rats expressed more TNF-α, IL-12, IL-6 and IL-23,
and exhibited the enhanced Th1/Th17 driving capacity
in co-cultures with allogeneic CD4+ lymphocytes, when
compared with those cells from young strain-matched
rats [28]. The previous findings seem to be particularly
relevant in light of data indicating that brain tissue resi-
dent dendritic cells in steady state share a similar pheno-
type and genotype profiling with splenic dendritic cells,
as both dendritic cell subsets have a common precursor
as pre-dendritic cells or peripheral blood dendritic cells
that are derived from the bone marrow [32, 33]. In agree-
ment with the aforementioned data, our preliminary find-
ings indicated that AO rat susceptibility to EAE increases
with aging [28]. Consequently, we undertook a series of
experiments in order to elucidate cellular and molecular
mechanisms standing behind this phenomenon. For
this purpose, phenotypic and functional characteristics
of CD4+ T lymphocytes and antigen presenting cells
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from spinal cords and draining lymph nodes of young
and aged AO rats were examined in inductive and ef-
fector phases of EAE.
Results
Aged AO rats immunized for EAE develop mild chronic
disease
Differently from young AO rats, which were resistant to
the induction of clinical EAE, 14 animals out of 22 aged
rats immunized for EAE (i.e. 6 rats from 9 rats sacrificed
on the 16th d.p.i. and 8 rats from 13 rats, which were
followed until 60th d.p.i.) exhibited mild signs of the dis-
ease (Fig. 1). In aged rats, which developed EAE, the
clinical (neurological) score reached the plateau value
between 15th and the 16th d.p.i. (Fig. 1). In agreement
with the neurological findings, on the 16th d.p.i. greater
(p < 0.001) number of mononuclear cells was retrieved
from aged compared with young rat spinal cord (Fig. 1).
Aging increases the number of CD4+ TCRαβ +
lymphocytes infiltrating the spinal cord of AO rats
immunized for EAE
The analysis of spinal cord mononuclear cells isolated
on the 16th d.p.i. revealed slightly lower (p < 0.05) fre-
quency of CD4+ TCRαβ + lymphocytes (Fig. 2). However,
despite the lower frequency of the spinal cord infiltrating
CD4+ TCRαβ + lymphocytes, more (p < 0.001) the cells
was retrived from aged than young rat spinal cord
(Fig. 2). The greater number of CD4+ TCRαβ + lympho-
cytes in aged rat spinal cord did not reflect their better
survival, as the frequency of apoptotic cells was compar-
able among CD4+ TCRαβ + cells from aged and young
rats (Additional file 1: Figure S1).
Further analyses of the spinal cord infiltrating CD4+
TCRαβ + lymphocytes showed higher (p < 0.001) frequency
and number of CD134+ cells, presumably reactivated cells
[21, 34] in aged compared with young rats (Fig. 2).
Aging increases the frequency of IL-17+ cells among CD4+ T
lymphocytes infiltrating the spinal cord of rats immunized for
EAE
Considering the Th1/Th17 paradigm [3], the spinal cord
infiltrating CD4+ TCRαβ + lymphocytes were also ex-
amined for the expression of IL-17 and IFN-γ. Flow
cytometry analysis (FCA) revealed greater (p < 0.001)
relative and absolute numbers of IL-17+ cells within
the spinal cord infiltrating CD4+ TCRαβ + lympho-
cytes from aged compared with young rats (Fig. 3). In
accordance with the previous findings, the expression
of mRNA for IL-17, a Th17 signature cytokine, was
greater in freshly isolated (p < 0.01) and PMA- and
ionomycin-stimulated (p < 0.001) spinal cord mono-
nuclear cells from aged rats compared with their younger
counterparts (Fig. 3).
The frequency of IFN-γ + cells among CD4+TCRαβ +
lymphocytes infiltrating spinal cord was comparable be-
tween aged and young rats (Fig. 3). However, due to the
greater cellularity of CD4+ TCRαβ + subset, the number
of IFN-γ + cells was also greater (p < 0.001) in spinal cord
from aged compared with young rats (Fig. 3). Although
the frequency of IFN-γ + cells within CD4+ TCRαβ +
lymphocytes was comparable between aged and
young rats, the greater amount of mRNA for this
cytokine was found in fresh (p < 0.01) and PMA- and
ionomycin-stimulated (p < 0.001) spinal cord mono-
nuclear cells from aged compared with young rats
(Fig. 3).
Fig. 1 Aging diminishes resistance of AO rats to EAE development. (a) Aged and young AO rats were immunized with rat spinal cord homogenate in
complete Freund’s adjuvant and co-injected with Bordetella pertussis. The clinical course of EAE was evaluated daily. Neurological signs of EAE were scored
as indicated in the section Methods. Thirteen rats from each group were followed over a 60-day-long follow-up period in a preliminary experiment,
whereas 9 rats were sacrificed on the 16th d.p.i. (arrow in line graph) for analyses. Line graph indicates the daily neurological score of EAE in aged and
young AO rats. The first numbers in the brackets indicate the number of rats with clinical EAE, whereas the second number (22) indicates the total number
of immunized rats per group. (b) Scatter plot indicates the clinical score of EAE on the 16th d.p.i. in rats used for analyses. Horizontal lines within the scatters
represent the mean values. (c) Bar graph indicates the total number of mononuclear cells retrieved from spinal cords of aged and young rats on the
16th d.p.i. Data represent mean values ± SEM (n= 9/group). Data shown are from one of two independent experiments with similar results. ***p< 0.001
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Aging increases the frequency of GM-CSF+ cells among
CD4+ T lymphocytes infiltrating the spinal cord of rats
immunized for EAE
Next, the frequency of cells producing GM-CSF, which
is shown to play the central role in maintaining chronic
neuroinflammation [8, 35, 36], among CD4+ T lympho-
cytes was examined. The frequency of GM-CSF+ cells
among CD4+ T lymphocytes infiltrating spinal cord was
increased (p < 0.001) in aged rats when compared with
their younger counterparts (Fig. 4). Consistently, the ex-
pression of GM-CSF mRNA was upregulated (p < 0.001)
in both fresh and PMA- and ionomycin-stimulated
spinal cord mononuclear cells from aged rats compared
with young ones (Fig. 4).
Next, considering recent findings suggesting that in
neuroinflammation, apart from GM-CSF+ CD4+ T lym-
phocytes that do not express Th1, Th17 and Th2
signature cytokines, GM-CSF+ CD4+ T lymphocytes co-
producing IL-17 in mice [10], and IFN-γ in humans [37]
play significant pathogenic role, GM-CSF+ CD4+ T lym-
phocytes were examined for the production of IL-17 and
IFN-γ using FCA. Irrespective of rat age, the majority of
GM-CSF+ CD4+ spinal cord infiltrating T lymphocytes
exhibited IL-17-IFN-γ- phenotype (Fig. 4). The fre-
quency of these cells did not significantly differ within
spinal cord infiltrating GM-CSF+ CD4+ T cells from
aged and young rats (Fig. 4). Thus, since the frequency
of GM-CSF+ cells was convincingly higher within CD4+
T lymphocytes from aged rat spinal cord, the frequency
of GM-CSF + IL-17-IFN-γ- cells was also higher (16.30 ±
1.26 in aged vs 10.09 ± 0.91 in young rats; p < 0.01) among
CD4+ T lymphocytes infiltrating the spinal cord of aged
rats when compared with young ones. Next, the expres-
sion of mRNA for IL-4, Th2 signature cytokine, in spinal
Fig. 2 Aging increases the number of CD134 + CD4+ T cells in spinal cord of AO rats immunized for EAE. Lower flow cytometry dot plots show
CD134 vs CD4 staining of lymphocytes retrieved from spinal cords of (left) young and (right) aged rats on the 16th d.p.i. CD4+ TCRαβ + cells were
gated as shown in the upper flow cytometry dot plots. Numbers in the flow cytometry dot plots represent the percentage of (upper dot plots)
CD4+ TCRαβ + cells within spinal cord cells and (lower dot plots) CD134+ cells among CD4+ TCRαβ + lymphocytes. Bar graphs show the number
of (upper) CD4+ TCRαβ + cells and (lower) CD134 + CD4+ TCRαβ + cells in young and aged rat spinal cords. All results are presented as means ±
SEM (n = 9/group). Data are representative of one of two experiments with similar results. *p < 0.05; ***p < 0.001
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Fig. 3 Aging increases the number of IL-17+ CD4+ T cells infiltrating the spinal cord of AO rats immunized for EAE. (Panel a) Flow cytometry dot
plots indicate the expression of (upper) IL-17 and (lower) IFN-γ in CD4+ TCRαβ + lymphocytes from spinal cord of (left) young and (right) aged
rats on the 16th d.p.i. Numbers in the flow cytometry dot plots represent the percentage of cells in the indicated region. Bar graphs indicate the
number of (upper) IL-17 + CD4+ TCRαβ + and (lower) IFN-γ + CD4+ TCRαβ + lymphocytes in spinal cords from young and aged rats. (Panel b)
Bar graphs indicate the fold change in expression of mRNAs for IL-17 and IFN-γ in freshly isolated (Fresh) and PMA- and ionomycin-stimulated
(PMA + iono) mononuclear spinal cord cells from aged relative to young rats on the 16th d.p.i. as determined by RT-qPCR. Data are normalized
to β-actin (ACTB). All results are presented as means ± SEM (n = 9/group). Data are representative of one of two experiments with similar results.
**p < 0.01; ***p < 0.001
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Fig. 4 (See legend on next page.)
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cord mononuclear cells was examined. Irrespective of rat
age, the expression of IL-4 mRNA was below the limit of
accurate quantification. Considering that in the mouse
GM-CSF+ cells, which do not express Th1, Th17 and Th2
signature cytokines (termed Th-GM cells) express a simi-
lar pattern of GM-CSF and IL-3 production [10], IL-3
mRNA expression was examined in fresh and PMA- and
ionomycin-stimulated spinal cord mononuclear cells. The
expression of IL-3 mRNA was augmented in both fresh
(p < 0.01) and PMA- and ionomycin-stimulated (p < 0.001)
spinal cord mononuclear cells from aged rats compared
with young ones (Fig. 4). This finding, in conjunction with
the previous ones, could suggest the expansion of GM-
CSF CD4+ T lymphocytes on the account of cells that re-
semble mouse Th-GM cells, in aged rats. Furthermore,
within GM-CSF+ subset of CD4+ T lymphocytes, a sig-
nificant proportion of cells produced either IL-17 only or
both IL-17 and IFN-γ. A small subset of GM-CSF+ CD4+
T lymphocytes also produced IFN-γ (Fig. 4). The fre-
quency of IL-17+ and IFN-γ + single positive cells within
GM-CSF + CD4+ T lymphocytes infiltrating the spinal
cord of aged and young rats was comparable, whereas that
of IL-17 + IFN-γ + double positive cells was greater (p <
0.05) in aged rats (Fig. 4). Given that the frequency of all
GM-CSF+ cells was greater among CD4+ T lymphocytes
infiltrating the spinal cord of aged rats, the frequency of
GM-CSF + IL-17 + IFN-γ + was also greater (p < 0.01)
among these cells from aged (1.59 ± 0.08 %) compared
with young rats (0.57 ± 0.01 %). In mice [38], differently
from humans [37, 39], the triple cytokine-producing cells
are derived from plastic Th17 cells, and their pathogenic
propensity in EAE is related to GM-CSF production [38].
Considering that Th-GM cells in mice differentiate
under the influence of IL-7-mediated STAT5 signaling
[10], IL-7 mRNA expression was examined in spinal cord
tissue. Indeed, the expression of mRNA for IL-7 was up-
regulated (p < 0.001) in aged compared with young ani-
mals (Fig. 4). This further corroborated the previous
notion that GM-CSF + IL-17-IFN-γ- cells accumulating in
aged rat spinal cord resemble mouse Th-GM cells.
Next, given that in the mouse the differentiation of IL-
17 + IFN-γ + CD4+ T lymphocytes, whose pathogenicity
is related to GM-CSF production, is driven by IL-1β and
IL-23 [8, 9], the expression of mRNAs for these cyto-
kines was measured in spinal cord mononuclear cells.
The expression of mRNA for both the cytokines was
also upregulated (p < 0.001) in aged compared with
young animals (Fig. 4).
Aging leads to the expansion of CD11b + CD45hi cell
population in spinal cord of rats immunized for EAE on
the 16th d.p.i.
Although CD4+ TCRαβ + lymphocytes were more nu-
merous in spinal cord of aged rats, the expansion of
CD11b + cell population mainly contributed to the
greater number of mononuclear cells isolated from aged
rats. Thus, the proportion of CD11b + cells within
mononuclear cells isolated from aged rat spinal cord,
and their number were greater (p < 0.001) when com-
pared with young rats (Fig. 5). CD11b + spinal cord cell
population encompasses resident microglial cells,
monocyte-derived dendritic cells, also called inflamma-
tory dendritic cells [12, 40], and blood-borne macro-
phages [12]. On the basis of CD45 expression, within
microglial cell population, CD45lo (resting) and CD45int
(activated) cells can be distinguished [41, 42]. Although
extremely strongly activated microglia may express
CD45 at high levels (CD45hi) [42], inflammatory
dendritic cells and macrophages are suggested to be
CD11b + cells that predominantly display high surface
levels of CD45 in spinal cord [12, 40, 42]. It is difficult
to discriminate inflammatory dendritic cells from mac-
rophages based on phenotypic markers [40]. In agree-
ment with upregulated expression of GM-CSF in spinal
cord mononuclear cells [12], the greater cellularity of
CD11b + cell population from aged rats reflected mainly
the greater (p < 0.001) frequency and number of CD45hi
cells, presumably inflammatory dendritic cells/macro-
phages (Fig. 5). The frequency of CD45int cells among
CD11b + cells retrieved from aged rats was less (p <
0.001), but their number was greater (p < 0.001) com-
pared with young rats (Fig. 5). The boundaries between
CD45int and CD45hi expressing populations were settled
as previously described [21, 41, 42]. Considering that
(See figure on previous page.)
Fig. 4 Aging increases the frequency of GM-CSF+ cells within CD4+ T lymphocytes infiltrating the spinal cord of AO rats immunized for EAE.
(Panel a) Overlaid flow cytometry histograms show GM-CSF expression in CD4+ T cells isolated on the 16th d.p.i. using MACS (described in detail
in the section Methods) from spinal cords of (left) young and (right) aged rats. In the overlaid flow cytometry histograms left histograms (thin
grey line) represent nonspecific binding of secondary antibody. Flow cytometry dot plots show IFN-γ vs IL-17 staining of GM-CSF+ CD4+ T cells
retrieved from spinal cords of (left) young and (right) aged rats on the 16th d.p.i. Numbers in the flow cytometry profiles represent the percentage
of cells in the indicated region. (Panel b) Bar graphs indicate the fold change in expression of mRNAs for GM-CSF and IL-3 in freshly isolated
(Fresh) and PMA- and ionomycin-stimulated (PMA + iono) mononuclear spinal cord cells from aged relative to young rats on the 16th d.p.i. as
determined by RT-qPCR. (Panel c) Bar graphs indicate the fold change in expression of mRNAs for IL-1β and IL-23/p19 in spinal cord mononuclear
cells and IL-7 in spinal cord tissue from aged relative to young rats on the 16th d.p.i. as determined by RT-qPCR. Data are normalized to β-actin
(ACTB). All results are presented as means ± SEM (n = 9/group). The data, except for GM-CSF, are representative of one of two experiments with
similar results. *p < 0.05; **p < 0.01; ***p < 0.001
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upregulated CCL2 (monocyte chemoattractant protein-
1, MCP-1) expression is important for (i) the accumula-
tion of proinflammatory dendritic cells and macrophages
in the CNS during EAE [43, 44] and MS [45], and (ii)
chronic EAE development [46, 47], the expression of
mRNA for CCL2 was examined. Indeed, the expression
of CCL2 mRNAs was upregulated (p < 0.001) in aged
compared with young rat spinal cord (Fig. 5).
Considering that (i) activation of macrophages [48],
dendritic cells [49] and microglial cells [50] is mediated
in part by proinflammatory cytokine and TLR signaling
pathways that can be negatively regulated by suppressor
of cytokine signaling 1 (SOCS1), and (ii) that down-
regulation of its expression increases production of
proinflammatory cytokines and tissue damaging mediators
contributing to the development of chronic inflammatory
Fig. 5 Aging increases the number of all CD11b + nonlymphoid cells, and CD45hi CD11b + cells, recovered on the 16th d.p.i. from AO rat spinal
cord. (Panel a) Flow cytometry density plots indicate the expression of CD45 on CD11b + cells from spinal cord of (left) young and (right) aged
rats on the 16th d.p.i. CD11b + cells were gated as shown in the flow cytometry histograms. Numbers in the flow cytometry histograms represent
the percentage of CD11b + cells. R1 = CD11b + CD45hi cells; R2 = CD11b + CD45int cells. Numbers in the table represent the percentage of cells in
the indicated region (R). Bar graphs indicate the number of (upper) CD11b + and (lower left) CD11b + CD45int and (lower right) CD11b + CD45hi
spinal cord mononuclear cells retrieved from young and aged rats. (Panel b) Bar graphs indicate the fold change in mRNA expression for (a)
CCL2 in spinal cord tissue and (b) SOCS1 and (c) TNFα in spinal cord mononuclear cells from aged relative to young rats on the 16th d.p.i. as
determined by RT-qPCR. Data are normalized to β-actin (ACTB). All results are presented as means ± SEM (n = 9/group). Data are representative of
one of two experiments with similar results. ***p < 0.001
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autoimmune diseases, including MS and EAE [48, 51],
SOCS1 expression was also measeured. Indeed, SOCS1
mRNA expression was diminished (p < 0.001) in aged
compared with young rat spinal cord mononuclear cells
(Fig. 5). Consistently, apart from mRNAs for IL-23/p19,
IL-1β, the expression of mRNA for TNF-α was also sev-
eral fold greater (p < 0.001) in aged compared with young
rat spinal cord mononuclear cells (Fig. 5).
Aging increases the accumulation of CD11b + CD45hi cells
in spinal cord of AO rats on the 7th d.p.i.
Microglial cells become activated in the CNS before the
onset of clinical EAE [12]. Their activation is suggested
to precede the accumulation of inflammatory dendritic
cells and macrophages, which also occurs during the
preclinical stage of disease [11]. Thus, to further confirm
age-related increase in the accumulation of these cells in
spinal cord of AO rats immunized for EAE, on the 7th
d.p.i. CD11b + cells were examined for frequency and
number, and CD45 expression. Indeed, at this time-point
following the immunization, the greater (p < 0.05) number
of mononuclear cells was retrived from spinal cord of aged
compared with young rats, and among them greater (p <
0.001) frequency and number of CD11b + cells was de-
tected (Fig. 6). Within CD11b + cell population markedly
greater (p < 0.001) frequency and number of both CD45int
and CD45hi cells was found (Fig. 6). Additionally, although
on the 7th d.p.i. the frequency of the spinal cord infiltrat-
ing CD4+TCRαβ + lymphocytes was lower (p < 0.05),
their number was greater (p < 0.05) in aged compared with
young rats (Additional file 2: Figure S2).
Furthermore, SOCS1 mRNA expression in spinal cord
mononuclear cells was measured. As on the 16th d.p.i.,
the amount of mRNA for SOCS1 was diminished (p <
0.001) in spinal cord mononuclear cells from aged com-
pared with young rats (Fig. 6).
Immunization for EAE differently affects cellularity and
phenotypic profile of draining lymph nodes in aged and
young AO rats
Finally, considering that the encephalitogenic CD4+ T
cell are primed in draning lymph nodes, and that resis-
tence to EAE in GM-CSF deficient mice is likely to
occur due to inefficient T cell priming in the periphery
due to an absence of GM-CSF in the lymph node [12],
draining lymph node cells were examined for the num-
ber of CD4+ TCRαβ + lymphocytes and their expression
of activation molecules and IL-17 and GM-CSF.
Aging increases the number of activated CD4+ TCRαβ +
lymphocytes in draining lymph nodes from rats immunized
for EAE
The lymph node weight and total number of draining
lymph node cells were greater (p < 0.001) in aged than in
young rats immunized for EAE (Additional file 3: Figure
S3). To ascertain that these changes were related to
immunization with specific (auto)antigen, the same pa-
rameters were analyzed in age-matched rats injected
with adjuvant, i.e. CFA and Bordetella pertussis. There
were no age-related differences in the value of any of
these two parameters in rats injected with adjuvant
(Additional file file 3: Figure S3). This suggested that the
age-associated differences in draining lymph node
weight and cellularity in rats immunized for EAE were
related to the response to autoantigen(s). Furthermore,
the frequency of CD4+ TCRαβ + lymphocytes among
draining lymph node cells and their number were
greater (p < 0.001) in aged than in young rats immunized
for EAE (Fig. 7). However, only the frequency of CD4+
TCRαβ + lymphocytes was greater (p < 0.001) in aged
than in young rats injected with adjuvant, but this differ-
ence was less (12 % in rats injected with adjuvant vs
23.4 % in rats immunized for EAE) pronounced in these
animals than in those immunized for EAE. The number
of draining node CD4+ TCRαβ + lymphocytes was
comparable between aged and young rats injected
with adjuvant (Fig. 7). Thus, age-related difference in
the number of CD4+ TCRαβ + lymphocytes in rats im-
munized for EAE could also be related to the re-
sponse to autoantigen(s).
Next, CD4+ lymphocytes from rats immunized for
EAE were examined for the expression of activation
markers. The relative and absolute numbers of CD134+
cells within CD4+TCRαβ + lymphocytes was greater (p <
0.001) in aged compared with young rats (Fig. 7). Given
that the values of all of these parameters were comparable
between aged and young rats injected with adjuvant
(Fig. 7), the age-associated differences observed in their
values in rats immunized for EAE could be ascribed to the
immunization with autoantigen(s).
Aging increases the frequency of IL-17+ cells among
CD4+ T lymphocytes in draining lymph nodes from rats
immunized for EAE
The frequency and number of IL-17+ cells within CD4+
TCRαβ + lymphocytes were greater (p < 0.001) in aged
than in young rats (Fig. 8). Consistently, the expression
of IL-17 mRNA was upregulated (p < 0.01) in freshly
isolated CD4+ cells from draining lymph nodes of aged
compared with young rats (Fig. 8). Additionally, in
MBP- and ConA-stimulated draining lymph node cell
cultures from aged rats the concentration of IL-17 was
greater (p < 0.01 and p < 0.001, respectively) than in the
corresponding cultures from young rats (Fig. 8).
Next, considering the previous findings, the expression
of the major cytokines driving Th17 cell differentiation,
i.e. IL-1β and IL-6, which are required for the induction
of IL-17 expression in naive cells, and IL-23, which
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Fig. 6 Aging increases the number of all spinal cord mononuclear cells, and CD45int/hi CD11b + nonlymphoid cells, recovered on the 7th d.p.i.
from AO rat spinal cord. (a) Bar graph indicates the total number of mononuclear cells (MNC) isolated from spinal cord of young and aged
rats on the 7th d.p.i. (Panel b) Flow cytometry density plots indicate the expression of CD45 on CD11b + cells from spinal cord of (left) young
and (right) aged rats on the 7th d.p.i. CD11b + cells were gated as shown in the flow cytometry histograms. Numbers in the flow cytometry
histograms represent the percentage of CD11b + cells. R1 = CD11b + CD45hi cells; R2 = CD11b + CD45int cells. Numbers in the table indicate the
percentage of cells in the specified region (R). Bar graph indicates the number of CD11b + cells in spinal cords from young and aged rats. (Panel
c) Bar graphs indicate the number of (left) CD11b + CD45int and (right) CD11b + CD45hi cells in spinal cords from young and aged rats on the 7th
d.p.i. (d) Bar graph indicates the fold change in expression of mRNA for SOCS1 in spinal cord mononuclear cells from aged relative to young rats
on the 7th d.p.i. as determined by RT-qPCR. Data are normalized to β-actin (ACTB). All results are presented as means ± SEM (n = 9/group). Data
are representative of one of two experiments with similar results. *p < 0.05; ***p < 0.001
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Fig. 7 (See legend on next page.)
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secures their survival, expansion and pathogenic capacity
[8, 9, 52, 53], was examined. The amount of IL-1β (p <
0.05) and IL-6 (p < 0.01) mRNAs was greater in aged rat
draining lymph node cells, whereas that of IL-23/p19
was comparable between aged and young rat draining
lymph node cells (Fig. 8).
Aging increases the frequency of GM-CSF+ cells among
CD4+ T lymphocytes in draining lymph nodes from rats
immunized for EAE
The frequency of GM-CSF+ cells among CD4+ draining
lymph node lymphocytes was also higher (p < 0.01) in
aged than in young rats (Fig. 9). Consistently, the ex-
pression of GM-CSF and IL-3 mRNAs was greater (p <
0.01 and p < 0.001, respectively) in freshly isolated CD4+
cells from aged compared with young rat draining lymph
nodes (Fig. 9). In addition, greater (p < 0.001) amount of
mRNAs for GM-CSF and IL-3 was also found in cells
from unstimulated and MBP-stimulated draining lymph
node cell cultures from aged rats (Fig. 9).
Next, GM-CSF + CD4+ draining lymph node lympho-
cytes were examined for IL-17 and IFN-γ production.
The majority of these cells did not contain either IL-17
or IFN-γ (Fig. 9). Given that in rats of both ages IL-4
mRNA expression was below the limit of detection, it
may be assumed that GM-CSF + IL-17-IFN-γ- cells did
not produce IL-4. The frequency of IL-17-IFN-γ- cells
among GM-CSF + CD4+ lymphocytes was comparable
between aged and young rats (Fig. 9). The relative num-
bers of cells belonging to other GM-CSF subsets were
almost negligiable. Thus, given that frequency of GM-
CSF+ cells was higher within CD4+ lymphocytes, it is
obvious that the expansion of GM-CSF+ CD4+ subset in
aged rats reflected mainly higher frequency of IL-17-
IFN-γ- cells (21.59 ± 1.21 % in aged vs 12.96 ± 0.98 % in
young rats; p < 0.01). Furthemore, as in the spinal cord,
the expression of mRNA for IL-7, the cytokine inducing
GM-CSF expression in mouse Th-GM lymphocytes [10],
was strikingly upregulated (p < 0.01) in aged compared
with young rat draining lymph node tissue (Fig. 9).
Discussion
The study showed that resistance of AO rats to EAE di-
minishes with aging. Differently from young rats, which
did not exhibit neurological deficit, majority of aged AO
rats developed chronic EAE with mild, but apparent
neurological deficit. This is in agreement with data
indicating that the age at immunization significantly
influences susceptibility to EAE in mice of both sexes
[54]. More specifically, it has been shown that in
B10.S x SJL/J F(2) intercross mice age effect is cap-
able of overriding eae5 (the H2-linked locus controlling
susceptibility to clinical disease)-dependent genetic con-
trol of susceptibility to clinical EAE [54]. Furthermore, it
should be pointed that the resistance of young adult AO
rats to EAE is not absolute, but quantitative, as minimal
single cell infiltrate is regularly seen (independently on
immunization protocol) in their spinal cord [27]. Add-
itionally, this resistance is suggested not to be due to im-
mune cell inability to recognize determinants of MBP, but
rather to the differences in immunoregulatory circuits op-
erating during the induction and/or effector phase of EAE
[26, 27]. Consistently, our study revealed several patho-
genetically significant differences in both effector and in-
ductive phase of EAE between young and aged AO rats.
In accordance with the differences in clinical outcome
of the immunization, on the 16th d.p.i. (when clinical
signs of EAE reached the plateau in aged rats) signifi-
cantly more mononuclear cells was retrieved from aged
compared with young rats. In addition, within the iso-
lated cell population from aged rats strikingly more
CD11b + cells was identified when compared with young
rats. The accumulation of CD45hi cells, presumably
mainly inflammatory dendritic cells and macrophages
[12, 40], contributed to the expansion of CD11b + popu-
lation in aged rats. This is consistent with data indicat-
ing that blood-borne myeloid cells, such as dendritic
cells and macrophages are a prominent constituent of
inflammatory infiltrates in the CNS during MS and EAE
[55, 56]. Furthermore, blood-borne myeloid cells, i.e.
proinflammatory dendritic cells and macrophages, are
shown to accumulate in the CNS of transgenic animals
that simultaneously express CCL2 and Fms-like tyrosine
kinase 3 ligand in the periphery, and these animals spon-
taneously develop meningeal and perivascular inflamma-
tion in association with an ascending paralysis [57]. In
other words, the neuroinflammation in this model (i) is
primarily driven by myeloid cells and (ii) it is not
(See figure on previous page.)
Fig. 7 Aging increases the number of CD134 + CD4+ T lymphocytes in draining lymph nodes of AO rats immunized for EAE. (Panel a) Flow
cytometry dot plots show CD4 vs TCRαβ staining of draining lymph node mononuclear cells from (left) young and (right) aged rats (upper dot
plots) injected with CFA and Bordetella pertussis (Adjuvant) or (lower dot plots) immunized for EAE (Immunized) on the 7th d.p.i. Bar graph shows
the number of CD4+ TCRαβ + cells in draining lymph nodes from young and aged rats injected with adjuvant or immunized for EAE. (Panel b)
Flow cytometry dot plots show CD134 vs CD4 staining of CD4+ TCRαβ + lymphocytes retrieved from draining lymph nodes of (left) young and
(right) aged rats (upper dot plots) injected with CFA and Bordetella pertussis (Adjuvant) or (lower dot plots) immunized for EAE on the 7th d.p.i.
Bar graph shows the number of CD134 + CD4+ TCRαβ + cells in draining lymph nodes from young and aged rats injected with adjuvant or
immunized for EAE. Numbers in the flow cytometry dot plots represent the percentage of cells in the indicated region. All results are presented
as means ± SEM (n = 9/group). Data are representative of one of two experiments with similar results. **p < 0.01; ***p < 0.001
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Fig. 8 Aging increases the frequency of IL-17+ cells among CD4+ T lymphocytes in draining lymph nodes from AO rats immunized for EAE.
(Panel a) Flow cytometry dot plots show the expression of IL-17 in CD4+ TCRαβ + lymphocytes retrieved on the 7th d.p.i. from draining lymph
nodes of (left) young and (right) aged rats immunized for EAE. Numbers in the flow cytometry dot plots indicate the percentage of cells in the
indicated region. Bar graph shows the number of IL-17 + CD4+ TCRαβ + lymphocytes in draining lymph nodes from young and aged rats. (Panel
b) Left bar graph indicates the fold change in expression of mRNA for IL-17 in CD4+ draining lymph node cells isolated on the 7th d.p.i. using
MACS (described in detail in the section Methods) from aged relative to young rats as determined by RT-qPCR. Data are normalized to β-actin
(ACTB). Right bar graph shows concentrations of IL-17 in 72 h lymph node mononuclear cell cultures from young and aged rats without ConA or
MBP (RPMI) or upon stimulation with either ConA (ConA) or MBP (MBP) as determined by ELISA. (Panel c) Bar graphs indicate the fold change in
expression of mRNAs for (left) IL-1β and IL-23/p19 and (right) IL-6 in draining lymph node cells on the 7th d.p.i. from aged relative to young rats
as determined by RT-qPCR. All results are presented as means ± SEM (n = 9/group). Data are representative of one of two experiments with similar
results. *p < 0.05; **p < 0.01; ***p < 0.001
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dependent on either T or B lymphocytes [57]. The en-
hanced CCL2 expression has been associated with the
progression of the CNS pathology in two clinically
distinct mouse models of MS, i.e. Theiler's murine en-
cephalomyelitis virus-induced demyelinating disease and
relapsing-remitting EAE [58], and the development of
relapse of autoimmune encephalomyelitis in Lewis rats
[59]. Thus, the upregulated expression of mRNA for
CCL2 in aged compared with young rat spinal cord
tissue corroborated the increased accumulation of
proinflammatory dendritic cells and macrophages in the
spinal cord of aged rats. The increased accumulation of
proinflammatory dendritic cells, which are thought to be
licensed to induce polarization of pathogenic Th17 cells
[11], and macrophages in the spinal cord during EAE
has been related to the enhanced production of GM-
CSF by infiltrating CD4+ T lymphocytes [11, 13]. GM-
CSF has been suggested to accelerate the release of bone
marrow precursors (so that their number expands more
than 60-fold before the onset of EAE) that ultimately dif-
ferentiate into the CNS-infiltrating dendritic cells and
macrophages [11, 13]. Indeed, the expression of GM-
CSF mRNA was markedly enhanced in both freshly iso-
lated and in PMA- and ionomycin-stimulated spinal
cord mononuclear cells. Considering that IFN-γ produc-
tion by CD4+ T cells was dramatically increased follow-
ing priming by GM-CSF-treated microglia [35], the
augmented expression of GM-CSF may also explain the
upregulated expression of IFN-γ mRNA in aged rat
spinal cord mononuclear cells despite the comparable
frequency of IFN-γ + cells within CD4+ T lymphocytes
Fig. 9 Aging increases the frequency of GM-CSF+ cells among CD4+ T
lymphocytes in draining lymph nodes from AO rats immunized for
EAE. (Panel a) Overlaid Flow cytometry histograms show GM-CSF
expression in CD4+ T cells isolated from draining lymph nodes of (left)
young and (right) aged rats on the 7th d.p.i. using MACS (described in
detail in Methods). In the overlaid flow cytometry histograms left
histograms (thin grey line) represent nonspecific binding of secondary
antibody. Flow cytometry dot plots show IFN-γ vs IL-17 staining of
GM-CSF+ T cells retrieved from draining lymph nodes of (left) young
and (right) aged rats on the 7th d.p.i. Numbers in the flow cytometry
profiles represent the percentage of cells in the indicated region. (Panel
b) Left bar graphs show the fold change in expression of mRNAs for
(upper) GM-CSF and (lower) IL-3 in CD4+ draining lymph node cells
isolated on the 7th d.p.i. using MACS (described in detail in the section
Methods) from aged relative to young rats. Right bar graphs show the
fold change in expression of mRNAs for (upper) GM-CSF and (lower)
IL-3 in draining lymph node cells cultivated for 72 h in RMPI medium
from aged rats and MBP-stimulated cells from young and aged rats
relative to those from young rats cultivated in RMPI medium, as
determined by RT-qPCR. (c) Bar graph shows fold change in mRNA
expression for IL-7 in draining lymph node tissue on the 7th d.p.i.
from aged relative to young rats as determined by RT-qPCR. Data are
normalized to β-actin (ACTB). All results are presented as means ± SEM
(n = 9/group). The data, except for GM-CSF, are representative of one
of two experiments with similar results. **p < 0.01; ***p < 0.001
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infiltrating aged and young rat spinal cord. The greater
expression of GM-CSF mRNA in aged rat spinal cord
mononuclear cells was consistent with higher frequency
of GM-CSF+ cells within CD4+ T lymphocytes infiltrat-
ing the spinal cord of aged rats compared with young
ones. Moreover, within spinal cord infiltrating GM-CSF+
CD4+ T lymphocytes from aged rats the frequency of
IL-17 + IFN-γ + cells was greater when compared with
young rats. Unlike in humans, in whom GM-CSF is not
a specific cytokine of Th17 cells given its disconnection
from IL-17 expression, its production by RORγt- Th
cells, and its down-regulation by Th17 cell-priming cyto-
kines [37], GM-CSF + IL-17 + IFN-γ +CD4+ T lympho-
cytes are suggested to be highly pathogenic in mice [8, 9].
In addition, within CD4+ T lymphocytes infiltrating
spinal cord of aged rats the higher frequency of GM-
CSF + IL-17-IFN-γ- cells was found. These cells most
likely did not produce IL-4 in either young or aged rats.
The previous findings, in conjunction with the greater
expression of mRNA for IL-3, the cytokine showing the
same production pattern as GM-CSF in mouse CD4+ T
cells [10], in fresh and PMA- and ionomycin-stimulated
aged rat mononuclear spinal cord cells, and IL-7, the
cytokine driving GM-CSF expression in mouse Th-GM
lymphocytes [10], in aged rat spinal cord tissue, suggest
that the greater accumulation of GM-CSF+ CD4+ lym-
phocytes in spinal cord also contributed to more severe
clinical outcome of the immunization in aged compared
with young rats. It favor of the previous assumption are
data indicating that dysregulation of the IL-7/IL-7R axis
has long been implicated in autoimmune diseases, such
as type 1 diabetes, multiple sclerosis and rheumatoid
arthritis [60, 61].
Furthermore, the greater number of the spinal cord
infiltrating CD4+ TCRαβ + lymphocytes and greater fre-
quency and number of CD134+ reactivated cells among
them was consistent with the more severe clinical
outcome of the immunization in aged compared with
young rats.
We did not identify the bone marrow precursors that
ultimately differentiate into CNS-infiltrating dendritic
cells and macrophages in blood, but we showed that the
frequency of CD11b + cells expressing morphological
characteristics of monocytes/macrophages according to
FSC and SSC parameters was increased in blood from
aged rats immunized for EAE, but not in these rats
injected with adjuvant (Additional file 4: Figure S4).
Thus, it may be speculated that the increase in their fre-
quency in aged rats immunized for EAE was related to
the immunization with autoantigen(s). This was consist-
ent with age-associated increases in number of CD14 +
CD16+ inflammatory monocytes, which has been shown
in humans [62, 63]. The accumulation of inflammatory
dendritic cells and macrophages is shown to occur
during the preclinical stage of disease [11]. Indeed on
the 7th d.p.i. significantly greater proportion and number
of CD11b + cells was found within mononuclear cells re-
trieved from aged compared with young rat spinal cord.
Differently from young rat CD11b + cells, which encom-
passed negligible number of CD45hi cells indicating a
lack of spinal cord infiltration with inflammatory den-
dritic cells and macrophages [12], a significant frequency
of these cells was registered among CD11b + cells from
aged rats. Consequently, on the 7th d.p.i., in addition to
activated microglial CD45int cell number, the number of
CD45hi cells, presumably mainly inflammatory dendritic
cells and macrophages [12, 40], was strikingly greater in
aged than in young rat spinal cord.
Next, considering that the downregultion of SOCS1
expression is shown to be involved in the development
of MS and EAE [48, 51], the expression of mRNA for
this cytokine in spinal cord mononuclear cells was also
measured. Indeed, SOCS1 mRNA expression was less in
spinal cord mononuclear cells from aged compared with
young rats. Consistently, on the 16th d.p.i. the expression
of proinflammatory cytokines IL-1β, IL-23/p19 and
TNF-α was markedly upregulated in spinal cord mono-
nuclear cells from aged compared with young rats. Thus,
it seems likely that the expansion of CD45int and CD45hi
subpopulations from aged rats was followed by en-
hanced expression of proinflammatory cytokines in these
cells due to dysregulation of their SOCS1 expression.
Given that resistence to EAE in GM-CSF deficient
mice is suggested to occur due to inefficient T- cell
priming in the draining lymph node to the myelin oligo-
dendrocyte glycoprotein [12], draining lymph node cells
were examined for the presence of activated CD4+ T
lymphocytes and the expression of GM-CSF. In agree-
ment with greater number of the spinal cord infiltrating
CD4+ TCRαβ + lymphocytes on the 7th and 16th d.p.i.,
the greater number of activated CD4+ TCRαβ + lympho-
cytes was found in draining lymph nodes from aged
compared with young rats. The analyses of CD4+
TCRαβ + lymphocyte profile in age-matched rats immu-
nized with CFA only showed that this difference was
specific to immunization with specific (auto)antigens.
This was consistent with data indicating the accumula-
tion of T cells with autoreactive specificities with aging
in both humans and experimental animals [20, 64]. This
phenomenon has been related to the erosion of naïve T
cell pool with aging, and consequent residual T-cell pro-
liferation to reconstitute their nearly normal numbers
[65]. In this compensatory event T cells with higher
avidity for self-peptide/MHC complexes enjoy advantage
and expand more relative to the low avidity T cells [20].
This leads to the accumulation of high avidity T cells,
which is potentially dangerous due to increased risk of
autoimmune disorders [66]. The lack of increase in the
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incidence of the most autoimmune diseases with aging
has been related to the expansion of many protective
regulatory mechanisms [64].
Furthermore, the greater expression of GM-CSF in
draining lymph node cells from aged rats following MBP
stimulation in vitro suggested enhanced production of
GM-CSF by encephalitogenic CD4+ draining lymph
node T lymphocytes of aged compared with young rats.
FCA showed that GM-CSF+ CD4+ lymphocytes in
draining lymph nodes from rats of both ages exhibited
predominantly IL-17-IFN-γ- phenotype, whereas the fre-
quencies of cells belonging to other GM-CSF subsets
were almost negligible. The frequency of GM-CSF + IL-
17-IFN-γ- cells was greater within CD4+ lymphocytes
from aged rat draining lymph nodes. Consistently, IL-3
mRNA in fresh CD4+ draining lymph node lymphocytes
and IL-7 mRNA expression in draining lymph node tis-
sue was greater in aged than in young rats. In addition,
the higher frequency of IL-17+ cells among CD4+ drain-
ing lymph node lymphocytes from aged rats was found.
The expression profile of Th polarization driving cyto-
kines [52, 53] corroborated this finding. Consistently,
upon stimulation with MBP draining lymph node cells
from aged rats produced more IL-17 compared with the
corresponding cells from young rats. At the first glance,
our findings indicating an extremely limited frequency
of GM-CSF + IL-17 + IFN-γ + cells in draining lymph
nodes of aged rats were at odds with the observed fre-
quency of these cells in their spinal cord on the 16th
d.p.i. However, it should be pointed out that in mice the
expression of IL-23/p19, the crucial cytokine for GM-
CSF + IL-17 + IFN-γ + cells generation [8], in the CNS
occurs only after the onset of EAE [10]. Therefore, it is
assumed that: i) IL-23 is not required for the initiation
of EAE and ii) GM-CSF-producing Th-GM cells induce
the expression of IL-23 from dendritic cells, macrophages,
and other CNS-residential cells to sustain the inflamma-
tion, i.e. that pathogenic Th17 cells (co-producing IFN-γ
and GM-CSF) arise in the CNS to cooperate with Th-GM
subset in EAE development [10].
Conclusions
In conclusion, the study supports the notion that aging
may overcome genetic resistance to EAE [54], and points
to mechanisms standing behind this phenomenon in AO
rats. More specifically, it indicates that enhanced gener-
ation of encephalitogenic GM-CSF + IL-17-IFN-γ- CD4+
T lymphocytes in draining lymph nodes and their enhanced
infiltration in the spinal cord leads to upregulation of IL-23
in innate immune cells from aged rat spinal cord. Conse-
quently, the generation of pathogenic GM-CSF + IL-17 +
IFN-γ +CD4+ T lymphocytes increases in spinal cord, and
they, together with accumulated proinflammatory blood-
borne myeloid cells, secure sustained neuroinflammation




Female young (2-3-month-old) and aged (24-26-month-
old) AO rats obtained from a breeding colony in the
animal facility of the Immunology Research Centre
“Branislav Janković” in Belgrade were used in the present
study. The animals were maintained under a 12-h light/
dark cycle in a temperature-controlled environment and
were provided with standard laboratory food and tap
water ad libitum. All experimental procedures and ani-
mal care were performed in accordance with the Direct-
ive 2010/63/EU of the European Parliament and of the
Council on the protection of animals used for scientific
purposes (revising Directive 86/609/EEC) and approved
by the Institutional Animal Care and Use Committee. In
the preliminary experiment, 13 of 22 rats were followed
over a 60-day-long follow-up period. Differently from
young rats, which did not develop clinical EAE, a signifi-
cant percentage (63 %) of aged rats exhibited neuro-
logical deficit. This deficit reached plateau on the 16h
d.p.i. in aged rats. For analyses rats (9 per group) were
sacrificed on the 16th d.p.i. In the subsequent experi-
ments, on the 16th d.p.i. the spinal cord tissue was col-
lected from rats of both ages for: i) cytokine/chemokine
quantification using RT-qPCR and ii) isolation of mono-
nuclear cells for FCA and proinflammatory mediator
and/or SOCS1 expression measurement using RT-qPCR.
Besides, on the 7th d.p.i. spinal cords and draining lymph
nodes were isolated. The mononuclear cells were sub-
jected to FCA of surface and/or intracellular antigen
expression and/or SOCS1/cytokine RT-qPCR and/or
ELISA quantification. To provide reasonable number of
spinal cord mononuclear cells for analyses, spinal cord
mononuclear cells were pooled (3 spinal cords/pool).
Induction and clinical evaluation of EAE
EAE was induced by an intradermal injection of 100 μl
of an emulsion made of equal volumes of rat spinal cord
homogenate in phosphate-buffered saline (PBS) and
CFA containing 1 mg/ml of heat-killed and dried Myco-
bacterium tuberculosis H37Ra (Sigma-Aldrich Chemie
GmbH, Taufkirchen, Germany) in the left hind paw,
followed by a subcutaneous injection of 0.25 ml of sa-
line suspension of 5x108 Bordetella pertussis (obtained
from Institute of Virology, Vaccines and Sera "Torlak",
Belgrade, Serbia) on the dorsum of the same paw.
Rats were weighed and graded daily for neurological
signs by two independent experienced observers, as
follows: 0, no clinical signs; 0.5, distal tail atony; 1,
complete tail atony; 2, paraparesis; 3, paraplegia; 4,
tetraplegia, moribund state or death.
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Antibodies and immunoconjugates
For immunolabeling, the following mAbs were used:
phycoerythrin (PE)-conjugated anti-CD4 (clone OX-
38), biotin-conjugated anti-CD8 (clone OX-8), biotin-
conjugated anti-CD134 (clone OX-40), biotin-conjugated
anti-CD45 (clone OX-1), fluorescein isothiocyanate
(FITC)-conjugated anti-IFN-γ (clone DB-1), PE-conjugated
anti-IL17A (clone TC11-18H10), as well as peridinin-
chlorophyll-protein (PerCP)-conjugated streptavidin and
isotype controls, all obtained from BD Biosciences Phar-
mingen (Mountain View, CA, USA). FITC-conjugated anti-
CD11b (clone ED8) mAb was supplied by Serotec (Oxford,
UK). Alexa Fluor 647-conjugated TCRαβ (clone R73) and
PerCP/cyanine (Cy) 5.5-conjugated goat-anti mouse IgG
were provided by BioLegend (San Diego, CA, USA), while
purified anti-GM-CSF mAb (clone 83308) was purchased
from R&D Systems, Inc. (Minneapolis, MN, USA).
Isolation of mononuclear cells
For mononuclear cell isolation, rats were deeply anesthe-
tized by an i.p. injection of 80 mg/kg: 8 mg/kg of body
weight of ketamine: xylazine anesthetic solution (keta-
mine, 100 mg/ml Ketamidor, Richter Pharma AG, Wels,
Austria; xylasine, 20 mg/ml Xylased, Bioveta, Ivanovice
na Hané, Czech Republic and saline, mixed in a 1:0.5:8.5
ratio) and perfused with PBS. Following perfusion, spinal
cords and lymph nodes were removed, weighed and
grinded on 70 μm nylon cell strainer (BD Biosciences,
Erembodegem, Belgium) placed in a petri dish contain-
ing ice-cold phosphate buffered saline (PBS) supple-
mented with 2 % fetal calf serum (FCS, Gibco, Grand
Island, NY, USA) and 0.01 % NaN3 (Sigma-Aldrich Che-
mie GmbH) (FACS buffer) or RPMI 1640 medium
(Sigma-Aldrich Chemie GmbH) with 5 % FCS (spinal
cord cells). Thereby obtained spinal cord single-cell sus-
pensions were further fractioned on a discontinuous 40/
70 % Percoll (Sigma-Aldrich Chemie GmbH) gradient at
1000xg for 50 min. Spinal cord mononuclear cells from
the interface were collected and, as lymph node cells,
counted in 0.2 % trypan blue solution using an improved
Neubauer hemacytometer.
Analyses of cytokine intracellular staining and/or
expression in spinal cord and draining lymph node
mononuclear cells
Stimulation of spinal cord and lymph node mononuclear
cells for analyses of cytokine intracellular staining
Freshly isolated and MACS-sorted CD4+ spinal cord
and draining lymph node cells were cultured in 24-well
plates (Sarstedt AG & Co., Nümbrecht, Germany) in
500 μl culture medium supplemented with 200 ng/ml
phorbol 12-myristate 13-acetate (PMA, Sigma-Aldrich
Chemie GmbH) and 400 ng/ml ionomycin (Sigma-Al-
drich Chemie GmbH). The culture medium consisted of
RPMI 1640 supplemented with 2 mM L-glutamine
(Serva, Heidelberg, Germany), 1 mM sodium pyruvate
(Serva), 100 units/ml penicillin (ICN, Costa Mesa, CA,
USA), 100 μg/ml streptomycin (ICN) and 10 % FCS.
The plates were incubated in a humidified atmosphere
of 5 % v/v CO2 for 4 h at 37 °C. For intracellular staining
of cytokines 3 μg/ml of brefeldin A (eBioscience) was
added 2 h before the end of the assay. Following incuba-
tion, the cells were harvested for immunostaining and
RT-qPCR cytokine quantification.
Cultivation of draining lymph node cells for analyses of T-
cell cytokine production
All draining lymph node cell cultures were run in cul-
ture medium in a 5 % CO2 humidified air atmosphere.
For analysis of cytokine production, draining lymph
node cells were cultured for 72 h in the culture medium
alone or in culture medium supplemented with 20 μg/
ml MBP (Sigma-Aldrich Chemie GmbH) or 2.5 μg/ml
ConA (Sigma-Aldrich Chemie GmbH). Cells were col-
lected for RT-qPCR, whereas cell-free supernatants were
harvested and assayed for IL-17 by ELISA.
Isolation of CD4+ cells from draining lymph node cell
suspensions
To examine cytokine expression in CD4+ lymphocytes,
mononuclear cells from draining lymph node were sub-
jected to cell separation using MACS. In brief, draining
lymph node cell suspensions were incubated with rat
CD4 microbeads (clone OX-38, Miltenyi Biotec, Glad-
bach, Germany) for 15 min at 4 °C. After washing in
MACS buffer (degassed PBS with 0.5 % bovine serum al-
bumin and 2 mM ethylenediaminetetraacetic acid), the
cells were loaded onto LS column (Miltenyi Biotec) and
placed in the magnetic field of the Quadro MACS separ-
ator (Miltenyi Biotec) for positive selection. CD4+ spinal
cord T cells were purified using a two-step procedure.
Firstly, the spinal cord mononuclear cells were labeled
using rat CD8a microbeads (clone G28, Miltenyi Biotec)
and passed through a magnetic field for negative selection.
In the second step, CD8- cells were incubated with rat
pan T-cell microbeads (clone OX-52, Miltenyi Biotec) and
positively selected for T lymphocytes, as described above.
FCA revealed that positive fractions contained 90–95 % of
CD4+ cells.
RT-qPCR quantification of cytokine, chemokine and
SOCS1 mRNAs
Spinal cord and draining lymph node cells and/or tissue
samples were harvested using Nucleic Acid Purification
Lysis Solution (Applied Biosystems, Foster City, CA, USA)
and immediately stored at -70 °C until RNA purification.
Total RNA from either 1 × 105 lysed cells or spinal cord/
lymph node tissue homogenates was extracted using ABI
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Prism 6100 Nucleic Acid PrepStation system (Applied
Biosystems) and Total RNA Chemistry Starter Kit
(Applied Biosystems). The procedure included DNAse
treatment to ensure that no genomic DNA contamination
was present. Isolated RNA was converted to cDNA using
High Capacity cDNA Reverse Transcription Kit (Applied
Biosystems), in 20-μl reactions ran under optimal condi-
tions (10 min, 25 °C; 120 min, 37 °C; 5 s, 85 °C).
For the analysis of cytokine and enzyme expression,
triplicate 25-μl RT-qPCR reactions, containing 1x Taq-
Man Gene Expression Master Mix (Applied Biosystems),
1x mix of premade primer and hydrolysis probe sets
(TaqMan Gene Expression Assays, Applied Biosystems)
and 5 μl of cDNA template, were ran under the default
Applied Biosystems 7500 Real-Time PCR System con-
ditions (2 min at 50 °C, 10 min at 95 °C, followed by
40 cycles consisted of 15 s at 95 °C and 1 min at
60 °C incubations each).
All the procedures were performed according to the
manufacturers’ instructions. Predesigned TaqMan Gene
Expression Assays (Applied Biosystems) used in the
study are listed in Table 1. Relative differences in target
mRNA levels were assessed by the 2-ΔΔCt method with
SDS v1.4.0. software (Applied Biosystems), using β-actin
as a normalizer, as it has been suggested [67].
FCA
Before immunostaining, mononuclear cells isolated from
rat spinal cords and draining lymph nodes were exten-
sively washed in FACS buffer. All incubation steps were
performed in the dark on ice. The stained samples were
acquired on FACSCalibur or FACSVerse flow cytometer
(Becton Dickinson, Mountain View, CA, USA), using
CELLQuest or FACSuite v1.0.5.3841 software (Becton
Dickinson). FlowJo software version 7.8. (TreeStar Inc,
Ashland, OR, USA) was used to analyze the data for per-
centage of a marker-positive cells. Dead cells and debris
were excluded from the analyses by selective gating
based on forward scatter (FSC) and side scatter (SSC),
whereby background staining level for each fluoro-
chrome type was defined using non-specific IgG isotype-
matched controls. Fluorescence minus one (FMO) con-
trols were applied to settle gating boundaries [21].
Surface antigen immunostaining
Cells were incubated with saturating concentrations of
either fluorochrome-labeled (direct fluorescence) or
biotin-conjugated (indirect fluorescence) mAbs for
30 min and washed. When biotin-conjugated mAbs were
applied, cells were incubated with PerCP-conjugated
streptavidin for additional 30 min and then a final
washing step was undertaken before re-suspending the
cells in PBS. To determine cell apoptosis, after labeling
with PE-conjugated anti-CD4 and Alexa Fluor 647-
conjugated anti-TCRαβ mAb cocktail, spinal cord cells
were washed with PBS and then with 1 X Annexin V
binding buffer (BD Pharmingen). After washing, the cells
were incubated with 5 μl Annexin V-FITC (BD Phar-
mingen) for 15 min at room temperature in the dark
and collected for FCA.
Intracellular cytokine staining
Spinal cord and lymph node mononuclear cells stimu-
lated with PMA and ionomycin were stained for surface
TCRαβ and CD8 antigens and then washed and fixed/
permeabilized overnight at 4 °C, using the solutions
from fixation/permeabilization buffer kit (eBioscience;
http://www.ebioscience.com/resources/best-protocols/flow-
cytometry-protocols.htm). Next, for double IFN-γ/IL-17
staining, the cells were washed using appropriate
Table 1 Summary of mRNA targets and reference gene for RT-qPCR analysis
Symbol Gene name Accession No.a Assay ID
1 Il1b Interleukin 1 beta NM_031512.2 Rn99999009_m1
2 Il3 Interleukin 3 NM_031513.1 Rn00580435_m1
3 Il4 Interleukin 4 NM_201270.1 Rn99999010_m1
4 Il6 Interleukin 6 NM_012589.1 Rn99999011_m1
5 Il7 Interleukin 7 NM_013110.2 Rn00681900_m1
6 Il17a Interleukin 17A NM_001106897.1 Rn01757168_m1
7 Il23a Interleukin 23, alpha subunit p19 NM_130410.2 Rn00590334_g1
8 Ifng Interferon gamma NM_138880.2 Rn00594078_m1
9 Csf2 Colony stimulating factor 2 (granulocyte-macrophage) NM_053852.1 Rn01456850_m1
10 Tnf Tumor necrosis factor NM_012675.3 Rn99999017_m1
11 Ccl2 Chemokine (C-C motif) ligand 2 NM_031530.1 Rn00580555_m1
12 Socs1 Suppressor of cytokine signaling 1 NM_145879.2 Rn00595838_s1
13 Actb Actin, beta NM_031144.2 Rn00667869_m1
aRefSeq: NCBI Reference Sequence Database
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permeabilization buffer (eBioscience), incubated with
fluorochrome-conjugated anti-IFN-γ and anti-IL-17
mAbs for 30 min at room temperature in the dark,
and then washed again and collected for FCA. For
GM-CSF analyses, the fixed MACS-sorted CD4+
cells were sequentially labeled using anti-GM-CSF
mAb, PerCP/Cy5.5-conjugated goat anti-mouse IgG
and fluorochrome-conjugated anti-IFN-γ/anti-IL-17
mAb cocktail, as described above.
ELISA
For measuring the IL-17 concentration commercial kit
(BioLegend) was used. The assay was performed follow-
ing the manufacturer’s instructions. A standard curve
was generated with the limit of detection for IL-17 of
8 pg/ml.
Statistical analysis
The statistical significance of differences between
groups was assessed using One-way ANOVA followed
by Tukey test for post hoc comparisons or Student's
unpaired t-test. All statistical analyses were performed
using GraphPad Prism 5 software (GraphPad Software,
Inc., La Jolla, CA, USA). Values of p ≤ 0.05 were consid-
ered significant.
Additional files
Additional file 1: Figure S1. Aging does not change the percentage of
apoptotic cells among CD4+ TCRαβ + cells in spinal cord of AO rats
immunized for EAE. Flow cytometry dot plots show Annexin V vs CD4
staining of T lymphocytes retrieved from spinal cords of (left) young
and (right) aged rats on the 16th d.p.i. Numbers in the flow cytometry
dot plots represent the percentage of Annexin V+ cells among CD4+
TCRαβ + lymphocytes. Results are presented as means ± SEM (n = 9/
group). Data are representative of one of two experiments with similar
results. (TIFF 228 kb)
Additional file 2: Figure S2. Aging increases the number of spinal
cord CD4+ TCRαβ + cells on the 7th d.p.i. in AO rats immunized for EAE.
Flow cytometry dot plots show TCRαβ vs CD4 staining of lymphocytes
retrieved from spinal cords of (left) young and (right) aged rats on the 7th
d.p.i. Numbers in the flow cytometry dot plots represent the percentage
of CD4+ TCRαβ + lymphocytes. Bar graph shows the number of CD4+
TCRαβ + cells in young and aged rat spinal cords. Results are presented
as means ± SEM (n = 9/group). Data are representative of one of two
experiments with similar results. *p < 0.05. (TIFF 562 kb)
Additional file 3: Figure S3. Aging increases weight and cellularity of
draining lymph nodes from AO rats immunized for EAE. Bar graphs
indicate the (left) lymph node (LN) weight and (right) number of draining
lymph node mononuclear cells (MNC) from young and aged rats injected
with CFA and Bordetella pertussis (Adjuvant) or immunized for EAE
(Immunized). All results are presented as means ± SEM (n = 9/group).
Data are representative of one of two experiments with similar results.
*p < 0.05; ***p < 0.001. (TIFF 168 kb)
Additional file 4: Figure S4. Aging increases the frequency of CD11b
+ cells with monocyte/macrophage physical characteristics in peripheral
blood from rats immunized for EAE. (Panel A) Flow cytometry dot plots
indicate peripheral blood CD11b +monocyte/macrophage gating
strategy. Flow cytometry dot plot indicates (right) CD11b expression
on monocytes/macrophages gated according to FSC and SSC as shown
in (left) flow cytometry dot plot. (B) Bar graph shows percentage of
CD11b +monocytes/macrophages within peripheral blood cells from
young and aged rats injected with CFA and Bordetella pertussis (Adjuvant)
or immunized for EAE (Immunized). All results are presented as means ±
SEM (n = 9/group). Data are representative of one of two experiments
with similar results. ***p < 0.001. (TIFF 1294 kb)
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